Home > Financial Ratios > GLENMARK LIFE SCIENCES

GLENMARK LIFE SCIENCES
Core EBITDA Growth

    Back to All Ratios
GLENMARK LIFE SCIENCES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for GLENMARK LIFE SCIENCES
Please provide your vote to see the results

GLENMARK LIFE SCIENCES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Growth(%) 6.426.5722.3095.01-

What is the latest Core EBITDA Growth ratio of GLENMARK LIFE SCIENCES ?

The latest Core EBITDA Growth ratio of GLENMARK LIFE SCIENCES is 6.42 based on Mar2023 Standalone results.
Year Core EBITDA Growth
Mar20236.42
Mar20226.57
Mar202122.30
Mar202095.01
Mar2019-

How is Core EBITDA Growth of GLENMARK LIFE SCIENCES Trending?

Years Core EBITDA Growth % Change
Mar2023 6.42
-2.28
Mar2022 6.57
-70.54
Mar2021 22.3
-76.53
Mar2020 95.01
0
Mar2019 0 -

Other Financial Ratios of GLENMARK LIFE SCIENCES


Compare Core EBITDA Growth ratio of peers of GLENMARK LIFE SCIENCES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES ₹10,160.8 Cr 1.9% 5.7% 66.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹361,916.0 Cr 0.3% -7.5% 53.9% Stock Analytics
CIPLA ₹115,034.0 Cr 1.1% -4.8% 56.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,929.0 Cr 1.6% 1.6% 27.6% Stock Analytics
DIVIS LABORATORIES ₹104,873.0 Cr -1.9% 10.7% 21.4% Stock Analytics
ZYDUS LIFESCIENCES ₹100,322.0 Cr 5.2% -0.2% 90.1% Stock Analytics


GLENMARK LIFE SCIENCES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK LIFE SCIENCES

1.9%

5.7%

66.9%

SENSEX

-0.6%

0.3%

21.8%


You may also like the below Video Courses